Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuliana Lista

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Urologic Oncology|October 11, 2014
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal massesAlessandro Larcher, Nicola Fossati, Francesco Mistretta, et al.
BJU International|April 11, 2012
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancerGiovanni Lughezzani, Andrea Gallina, Alessandro Larcher, et al.
The Journal of Urology|August 21, 2012
Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsyMassimo Lazzeri, Alberto Briganti, Vincenzo Scattoni, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 4, 2018
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single centerRodolfo Hurle, Nicolò Buffi, Giuliana Lista, et al.
European Urology Oncology|June 4, 2019
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance ProjectRodolfo Hurle, Piergiuseppe Colombo, Massimo Lazzeri, et al.
Urology|December 10, 2013
Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examinationMassimo Lazzeri, Alberto Abrate, Giovanni Lughezzani, et al.
The Journal of Urology|March 8, 2013
Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsyVincenzo Scattoni, Massimo Lazzeri, Giovanni Lughezzani, et al.
European Urology Focus|July 21, 2017
Minimally Invasive Partial Nephrectomy Versus Laparoscopic Cryoablation for Patients Newly Diagnosed with a Single Small Renal MassNicola Fossati, Alessandro Larcher, Giulio M Gadda, et al.
Journal of Clinical Medicine|July 27, 2024
The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center StudyLuca Di Gianfrancesco, Isabella Monia Montagner, Debora Tormen, et al.
European Urology|December 24, 2013
Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsyGiovanni Lughezzani, Massimo Lazzeri, Alexander Haese, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Urologic Oncology|October 11, 2014
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal massesAlessandro Larcher, Nicola Fossati, Francesco Mistretta, et al.
BJU International|April 11, 2012
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancerGiovanni Lughezzani, Andrea Gallina, Alessandro Larcher, et al.
The Journal of Urology|August 21, 2012
Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsyMassimo Lazzeri, Alberto Briganti, Vincenzo Scattoni, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 4, 2018
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single centerRodolfo Hurle, Nicolò Buffi, Giuliana Lista, et al.
European Urology Oncology|June 4, 2019
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance ProjectRodolfo Hurle, Piergiuseppe Colombo, Massimo Lazzeri, et al.
Urology|December 10, 2013
Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examinationMassimo Lazzeri, Alberto Abrate, Giovanni Lughezzani, et al.
The Journal of Urology|March 8, 2013
Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsyVincenzo Scattoni, Massimo Lazzeri, Giovanni Lughezzani, et al.
European Urology Focus|July 21, 2017
Minimally Invasive Partial Nephrectomy Versus Laparoscopic Cryoablation for Patients Newly Diagnosed with a Single Small Renal MassNicola Fossati, Alessandro Larcher, Giulio M Gadda, et al.
Journal of Clinical Medicine|July 27, 2024
The Feasibility and Diagnostic Adequacy of PD-L1 Expression Analysis Using the Cytoinclusion Technique in Bladder Cancer: A Prospective Single-Center StudyLuca Di Gianfrancesco, Isabella Monia Montagner, Debora Tormen, et al.
European Urology|December 24, 2013
Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsyGiovanni Lughezzani, Massimo Lazzeri, Alexander Haese, et al.
Pageof 5